United Kingdom Breast Biopsy Devices Market Insight
Published: 17 June 2026 | Report Format: Electronic (PDF)
The United Kingdom Breast Biopsy Devices Market is projected to grow at a CAGR of around 7.2%, driven by increasing breast cancer screening programs and continuous advancements in minimally invasive biopsy technologies.
United Kingdom Breast Biopsy Devices Market Forecasts to 2035
- The United Kingdom Breast Biopsy Devices Market size was estimated at approximately USD 0.24 Billion in 2025.
- The market is expected to grow at a CAGR of around 7.1% from 2025 to 2035.
- The United Kingdom Breast Biopsy Devices Market is projected to reach approximately USD 0.48 Billion by 2035.
Notable Insights for the United Kingdom Breast Biopsy Devices Market
- Segmentation based on product type indicate Vacuum-Assisted Breast Biopsy Devices account for approximately 42% market share in 2025, driven by increasing preference for minimally invasive and highly accurate tissue sampling procedures.
- Segmentation based on application shows Breast Cancer Diagnosis holding nearly 68% market share in 2025, supported by expanding screening programs and growing incidence of breast cancer.
- The United Kingdom Breast Biopsy Devices Market is led by major manufacturers including Hologic Inc., BD (Becton Dickinson), Danaher Corporation (Leica Biosystems), Argon Medical Devices, and Cook Medical, collectively accounting for approximately 54% market share in 2025.
- Growing investments in image-guided biopsy technologies, digital pathology solutions, and oncology diagnostic infrastructure have increased adoption of advanced breast biopsy procedures by nearly 33% over the past five years.
Download the eBook (ToC)
Why Buy This Report
- Provides in-depth analysis of breast biopsy device demand across hospitals, diagnostic imaging centers, specialty oncology clinics, and ambulatory care facilities.
- Covers detailed insights into vacuum-assisted biopsy systems, core needle biopsy devices, image-guided procedures, and emerging diagnostic technologies.
- Helps stakeholders evaluate competitive positioning, growth opportunities, and investment potential within the United Kingdom breast cancer diagnostics ecosystem.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the United Kingdom Breast Biopsy Devices Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in United Kingdom Breast Biopsy Devices Market
- Hologic Inc.
- BD (Becton, Dickinson and Company)
- Danaher Corporation (Leica Biosystems)
- Argon Medical Devices Inc.
- Cook Medical LLC
- Cardinal Health Inc.
- Mammotome (Canon Medical Systems)
- Devicor Medical Products Inc.
- Merit Medical Systems Inc.
- SOMATEX Medical Technologies GmbH
Recent Developments:
- In May 2025, Hologic expanded its breast health portfolio with advanced image-guided biopsy solutions designed to improve diagnostic accuracy and procedural efficiency.
- In February 2025, Mammotome introduced enhanced vacuum-assisted breast biopsy technology featuring improved tissue acquisition capabilities and patient comfort features.
Market Segmentation:
United Kingdom Breast Biopsy Devices Market, By Product Type
- Core Needle Biopsy Devices
- Vacuum-Assisted Breast Biopsy Devices
- Fine Needle Aspiration Biopsy Devices
- Localization Devices
- Biopsy Guidance Systems
United Kingdom Breast Biopsy Devices Market, By Application
- Breast Cancer Diagnosis
- Research Applications
- Tumor Characterization
- Screening & Early Detection
United Kingdom Breast Biopsy Devices Market, By End User
- Hospitals
- Diagnostic Imaging Centers
- Specialty Oncology Clinics
- Ambulatory Surgical Centers
- Academic & Research Institutes
Expert Views:
The United Kingdom Breast Biopsy Devices Market is expected to witness strong growth through 2035, supported by rising breast cancer prevalence, increasing adoption of minimally invasive diagnostic procedures, and expanding national screening initiatives. Continuous innovation in image-guided biopsy systems, AI-assisted diagnostic workflows, precision oncology technologies, and patient-centered care solutions is anticipated to improve diagnostic outcomes and strengthen long-term market growth across the healthcare sector.
Author: Sanket and Pranali By Decisions Advisors and Consulting